Piramal Pharma Raises Stake in Yapan Bio
· Business · Business Standard
Piramal Pharma has increased its shareholding in Yapan Bio, according to Business Standard. The report does not disclose the new stake percentage or the transaction value. It also does not explain why Piramal is expanding its investment in the company. No additional information about the impact on Yapan Bio’s operations or market positioning is provided.
Why it matters
The move signals growth interest from a major Indian pharma player and could affect Yapan Bio’s future funding and strategic direction.
Read the original report — Business Standard
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.